Nurix Therapeutics, Inc. NRIX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration revenue | $6.25M-54.0% | $13.58M+72.0% | $7.89M-43.8% | $14.06M-23.8% | $18.45M+38.9% | |
| License revenue | $30M— | —— | $15M0.0% | $15M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nurix Therapeutics, Inc. break its business down?
- Nurix Therapeutics, Inc. (NRIX) reports revenue by product across 2 parts — Collaboration revenue and License revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nurix Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nurix Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
